These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 9918218)
1. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. Stearns ME; Rhim J; Wang M Clin Cancer Res; 1999 Jan; 5(1):189-96. PubMed ID: 9918218 [TBL] [Abstract][Full Text] [Related]
2. IL-10 inhibition of human prostate PC-3 ML cell metastases in SCID mice: IL-10 stimulation of TIMP-1 and inhibition of MMP-2/MMP-9 expression. Stearns ME; Fudge K; Garcia F; Wang M Invasion Metastasis; 1997; 17(2):62-74. PubMed ID: 9561025 [TBL] [Abstract][Full Text] [Related]
3. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice. Stearns ME; Garcia FU; Fudge K; Rhim J; Wang M Clin Cancer Res; 1999 Mar; 5(3):711-20. PubMed ID: 10100726 [TBL] [Abstract][Full Text] [Related]
4. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines. Wang M; Fudge K; Rhim JS; Stearns ME Oncol Res; 1996; 8(7-8):303-15. PubMed ID: 8938794 [TBL] [Abstract][Full Text] [Related]
5. Interleukin 10 blocks matrix metalloproteinase-2 and membrane type 1-matrix metalloproteinase synthesis in primary human prostate tumor lines. Stearns ME; Wang M; Hu Y; Garcia FU; Rhim J Clin Cancer Res; 2003 Mar; 9(3):1191-9. PubMed ID: 12631625 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 activation of the interleukin-10E1 pathway and tissue inhibitor of metalloproteinase-1 expression is enhanced by proteasome inhibitors in primary prostate tumor lines. Stearns ME; Wang M; Hu Y; Garcia FU Mol Cancer Res; 2003 Jul; 1(9):631-42. PubMed ID: 12861049 [TBL] [Abstract][Full Text] [Related]
7. IL-10 blocks collagen IV invasion by "invasion stimulating factor" activated PC-3 ML cells: upregulation of TIMP-1 expression. Stearns ME; Wang M; Stearns M Oncol Res; 1995; 7(3-4):157-63. PubMed ID: 8555649 [TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells. Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411 [TBL] [Abstract][Full Text] [Related]
9. Immunoassays of the metalloproteinase (MMP-2) and tissue inhibitor of metalloproteinase (TIMP 1 and 2) levels in noninvasive and metastatic PC-3 clones: effects of taxol. Stearns ME; Wang M Oncol Res; 1994; 6(4-5):195-201. PubMed ID: 7841542 [TBL] [Abstract][Full Text] [Related]
10. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243 [TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464 [TBL] [Abstract][Full Text] [Related]
12. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. Zhang Y; McCluskey K; Fujii K; Wahl LM J Immunol; 1998 Sep; 161(6):3071-6. PubMed ID: 9743373 [TBL] [Abstract][Full Text] [Related]
13. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1. Aoudjit F; Potworowski EF; St-Pierre Y J Immunol; 1998 Mar; 160(6):2967-73. PubMed ID: 9510201 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474 [TBL] [Abstract][Full Text] [Related]
16. Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis. Yang JH; Wu MY; Chen MJ; Chen SU; Yang YS; Ho HN Fertil Steril; 2009 May; 91(5 Suppl):2193-8. PubMed ID: 18692810 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Ries C; Loher F; Zang C; Ismair MG; Petrides PE Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer; tumor neovasculature and the effect of tissue inhibitor of metalloproteinases-1 (TIMP-1) on angiogenesis. Thorgeirsson UP; Yoshiji H; Sinha CC; Gomez DE In Vivo; 1996; 10(2):137-44. PubMed ID: 8744792 [TBL] [Abstract][Full Text] [Related]
19. Interleukin 15 stimulates production of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by human peripheral blood mononuclear cells. Constantinescu CS; Grygar C; Kappos L; Leppert D Cytokine; 2001 Feb; 13(4):244-7. PubMed ID: 11237433 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases-1 and -2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients. Zdzisińska B; Walter-Croneck A; Kandefer-Szerszeń M Leuk Res; 2008 Nov; 32(11):1763-9. PubMed ID: 18472160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]